Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Methylnaltrexone" patented technology

This medication is used to treat constipation caused by opioid (narcotic) medication.

Use of methylnaltrexone and related compound to treat constipation in chronic opioid users

InactiveUS20100087472A1Improve the quality of lifeMaintains analgesic efficacyBiocideDigestive systemSide effectMedicine
A method of preventing or treating constipation in a patient who has been chronically taking opioids, the method comprising administering a quaternary derivative of noroxymorphone in an amount sufficient to prevent or treat the side effect in the patient, but which amount would be insufficient to treat a patient with the same opioid-induced side effect who had not chronically been administered opioids.
Owner:PROGENICS PHARMA NEVADA +1

Pharmaceutical formulation

Stable pharmaceutical compositions useful for administering methylnaltrexone are described, as are methods for making the same. Kits, including these pharmaceutical compositions, also are provided.
Owner:PROGENICS PHARMA INC

Use of methylnaltrexone to attenuate tumor progression

Presented herein are methods for preventing or treating tumor growth, tumor metastasis and / or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.
Owner:SALIX PHARMA INC +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products